alzheimer
- North America > United States > Illinois (0.05)
- Europe > France (0.04)
- Asia > Middle East > Republic of Türkiye > Karaman Province > Karaman (0.04)
- Asia > Middle East > Jordan (0.04)
- Research Report > Experimental Study (1.00)
- Research Report > New Finding (0.93)
- Health & Medicine > Diagnostic Medicine (0.93)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.71)
- Information Technology > Data Science (1.00)
- Information Technology > Artificial Intelligence > Representation & Reasoning > Uncertainty > Bayesian Inference (0.93)
- Information Technology > Artificial Intelligence > Machine Learning > Learning Graphical Models > Directed Networks > Bayesian Learning (0.93)
- (3 more...)
- Europe > United Kingdom > England > Cambridgeshire > Cambridge (0.04)
- Europe > United Kingdom > England > Greater London > London (0.04)
- Asia > China (0.04)
- Oceania > New Zealand > North Island > Auckland Region > Auckland (0.05)
- Asia > Singapore (0.04)
- Oceania > New Zealand > North Island > Gisborne District > Gisborne (0.04)
- (3 more...)
- Research Report > Experimental Study (1.00)
- Research Report > New Finding (0.93)
- Workflow (0.68)
- North America > United States > Oregon > Multnomah County > Portland (0.04)
- Asia > Middle East > Lebanon (0.04)
- Health & Medicine > Diagnostic Medicine > Imaging (0.94)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.73)
PUe: Biased Positive-Unlabeled Learning Enhancement by Causal Inference
Positive-Unlabeled (PU) learning aims to achieve high-accuracy binary classification with limited labeled positive examples and numerous unlabeled ones. Existing cost-sensitive-based methods often rely on strong assumptions that examples with an observed positive label were selected entirely at random. In fact, the uneven distribution of labels is prevalent in real-world PU problems, indicating that most actual positive and unlabeled data are subject to selection bias. In this paper, we propose a PU learning enhancement (PUe) algorithm based on causal inference theory, which employs normalized propensity scores and normalized inverse probability weighting (NIPW) techniques to reconstruct the loss function, thus obtaining a consistent, unbiased estimate of the classifier and enhancing the model's performance. Moreover, we investigate and propose a method for estimating propensity scores in deep learning using regularization techniques when the labeling mechanism is unknown. Our experiments on three benchmark datasets demonstrate the proposed PUe algorithm significantly improves the accuracy of classifiers on non-uniform label distribution datasets compared to advanced cost-sensitive PU methods.
- Oceania > Australia > New South Wales > Sydney (0.04)
- Europe > United Kingdom > England > Cambridgeshire > Cambridge (0.04)
- Europe > Germany > Bavaria > Lower Franconia > Würzburg (0.04)
- Europe > France > Centre-Val de Loire > Loiret > Orleans (0.04)
- Health & Medicine > Therapeutic Area > Pulmonary/Respiratory Diseases (1.00)
- Education (0.93)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.68)
- (2 more...)
- Information Technology > Data Science > Data Mining (1.00)
- Information Technology > Artificial Intelligence > Cognitive Science (0.68)
- Information Technology > Artificial Intelligence > Machine Learning > Reinforcement Learning (0.46)
- Information Technology > Artificial Intelligence > Machine Learning > Neural Networks (0.46)
Uncertainty-Aware Multimodal Learning via Conformal Shapley Intervals
Chandy, Mathew, Johnson, Michael, Shen, Judong, Mehrotra, Devan V., Zhou, Hua, Zhou, Jin, Dai, Xiaowu
Multimodal learning combines information from multiple data modalities to improve predictive performance. However, modalities often contribute unequally and in a data dependent way, making it unclear which data modalities are genuinely informative and to what extent their contributions can be trusted. Quantifying modality level importance together with uncertainty is therefore central to interpretable and reliable multimodal learning. We introduce conformal Shapley intervals, a framework that combines Shapley values with conformal inference to construct uncertainty-aware importance intervals for each modality. Building on these intervals, we propose a modality selection procedure with a provable op-timality guarantee: conditional on the observed features, the selected subset of modalities achieves performance close to that of the optimal subset. We demonstrate the effectiveness of our approach on multiple datasets, showing that it provides meaningful uncertainty quantification and strong predictive performance while relying on only a small number of informative modalities.
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.97)
- Education > Educational Setting (0.93)
- Health & Medicine > Diagnostic Medicine (0.68)
He Went to Prison for Gene-Editing Babies. Now He's Planning to Do It Again
He Went to Prison for Gene-Editing Babies. Now He's Planning to Do It Again Chinese scientist He Jiankui wants to end Alzheimer's and thinks Silicon Valley is conducting a "Nazi eugenic experiment." In 2018, a nervous-looking He Jiankui took the stage at a scientific conference in Hong Kong. A hush settled over the packed auditorium as the soft-spoken Chinese scientist adjusted his microphone and confirmed the circulating media reports: He had created the world's first gene-edited babies . Three little girls were born with modifications to their genomes that were intended to protect them against HIV. The changes he'd made to their DNA were permanent and heritable, meaning they could be passed down to future generations.
- North America > United States > California (0.35)
- Asia > China > Hong Kong (0.25)
- Africa > South Africa (0.06)
- (11 more...)
- Health & Medicine > Therapeutic Area > Infections and Infectious Diseases (0.90)
- Health & Medicine > Therapeutic Area > Immunology (0.90)
- Health & Medicine > Therapeutic Area > Genetic Disease (0.89)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.39)